English | Español

Merck
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Press release submission | Sep 23, 2019

MERCK: New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care
Press release submission | Aug 18, 2018

MERCK: Healthy Interactions and Merck Announce Launch of Digital Health Platform Designed to Enhance Patient Engagement in Diabetes Management
Carol Ostrow | May 16, 2018

FDA accepts two new drug applications for Merck HIV-1 therapy
Marian Johns | Jan 17, 2018

FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer
Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval
Carol Ostrow | Oct 15, 2017

Merck KGaA aims raise awareness, boost support for unpaid caregivers
Carol Ostrow | Oct 1, 2017

Merck to host meeting on third-quarter performance

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’